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Molecular Biology SelectThe successful survival and proliferation of a cell is contingent upon its ability to produce the correct proteins in the
correct amounts at the correct times. Myriad regulatory processes have evolved to orchestrate the intricate steps that
ensure expression of the appropriate genes when they are needed. This issue’s Molecular Biology Select discusses
recent reports that uncover or characterize new roles for regulatory mechanisms in translation.
SF2/ASF, Cellular Multitasker
Many steps lie between the genesis of an mRNA transcript and its translation
into protein. Mounting evidence suggests that the events surrounding
mRNA synthesis—splicing, export, and translation—are tightly coupled
rather than distinct enterprises. Indeed, the human protein SF2/ASF, a mem-
ber of the serine/arginine-rich (SR) protein family involved in RNA process-
ing, has been suggested to function not only in mRNA splicing but also in
mRNA export and translation. Recently, Michlewski et al. (2008) confirmed
and elucidated the mechanism for SF2/ASF regulation of translation in cul-
tured human cells. Their in vitro translation studies indicated that SF2/ASF
stimulates the translation of mRNAs containing both SF2/ASF binding sites
and a 50 m7GpppX cap structure (which must be bound by the cap binding
protein eIF4E before translation can begin). Activation of translation by SF2/
ASF is dependent on its ability to promote inactivation of the translational
inhibitor 4E-BP1 (eIF4E binding protein 1). SF2/ASF does this by promoting
the hyperphosphorylation of 4E-BP1 by the kinase mTOR. SF2/ASF also
interacts with the catalytic subunit of the 4E-BP1 phosphotase PP2A, pos-
sibly inhibiting its activity. Once hyperphosphorylated, 4E-BP1 loses its
binding affinity for eIF4E, allowing the initiation of translation. Indeed, in the
absence of SF2/ASF, 4E-BP1 remains in a hypophosphorylated form that
has high binding affinity for eIF4E. This elucidation of SF2/ASF regulatory
function sheds more light on the coupling of posttranscriptional mRNA processing and translation events. Furthermore, it
suggests a possible common mode of using mRNA processing proteins to specifically regulate the expression of a subset
of transcripts and ties these regulatory signals to the multifaceted mTOR signaling pathway.
G. Michlewski et al. (2008). Mol. Cell 30, 179–189.
Initiating Translation, Caps Optional
In the process of cap-independent mRNA translation, the ribosome is recruited to the mRNA at a position close to the initiating
codon independently of the 50 m7GpppX cap structure. This process—requiring an element known as an internal ribosomal
entry site (IRES) in the 50 untranslated region (UTR) of the mRNA—usually occurs during cell stress when cap-dependent
translation is inhibited. In new work, Marash et al. (2008) identify a role for the eIF4G protein DAP5 in the cap-independent
translation of Bcl-2 and CDK1 transcripts in unstressed cultured cells. When DAP5 is depleted from cultured HeLa cells, cas-
pase-dependent (apoptotic) cell death occurs during mitosis. The authors used two separate screens for DAP5 targets: one
searched for proteins whose levels change in DAP5-depleted cells relative to wild-type cells, and the other identified DAP5-
associated mRNAs. Through these two methods, Marash and colleagues identified the transcripts encoding the antiapoptotic
oncogene Bcl-2 and the central mitotic kinase CDK1/p34Cdc2 as targets of DAP5 regulation. Both transcripts harbor an IRES
element in their 50 UTR. In particular, depletion of DAP5 reduced the ability of the Bcl-2 IRES to initiate translation as well as
decreased the ribosome occupancy on Bcl-2 transcripts. Overexpression of either Bcl-2 or CDK1 in DAP5-depleted cells
resulted in partial suppression of cell death inducing caspase activation. This suggests that the cell death observed in
DAP5-depleted cells is due to an inability to make sufficient Bcl-2 or CDK1 protein. With these findings, Marash et al. add
to the growing body of evidence suggesting that cap-independent translation may be more than just an emergency mecha-
nism called upon in the odd moment when the cell is in a pinch. Instead, cells may use IRES-mediated translation initiation
more often than previously thought.
L. Marash et al. (2008). Mol. Cell. Published online May 1, 2008. 10.1016/j.molcel.2008.03.018.
New Molecules for Old Hat Regulation
The regulation of one protein by another in a pathway forms the basis for most mechanisms of gene expression regulation.
Urban and Vogel (2008) make the interesting discovery that small noncoding RNAs in bacteria can also form such hierarchical
regulatory cascades. In bacteria, small noncoding RNAs are known to regulate gene expression by modulating events at the
posttranscriptional level. In the bacterium Escherichia coli, the small noncoding RNAs, GlmY and GlmZ, positively regulate
The multifunctional splicing factor SF2/ASF pro-
motes splicing in the nucleus and activates initia-
tion of translation in the cytoplasm by recruiting
components of the mTOR signaling pathway.
Image courtesy of Javier F. Ca´ceres.Cell 133, May 16, 2008 ª2008 Elsevier Inc. 555
translation of glmS mRNA. GlmY and GlmZ are highly homologous to one another,
suggesting that they may act in a complementary manner to stimulate synthesis of
the GlmS protein. However, Urban et al. now find that GlmY cannot activate transla-
tion of the glmS transcript on its own and acts upstream of GlmZ in the GlmS regu-
latory pathway. In fact, GlmY directly regulates the amount of full-length functional
GlmZ by both prolonging the half-life of GlmZ and inhibiting a 30 mRNA processing
event that would remove the site on GlmZ that binds to the glmS transcript. It is
GlmZ that directly interacts with the glmS transcript to activate its translation. GlmY
activation of GlmZ (and thus GlmS) is also counterbalanced at the RNA level as 30 poly-
adenylation of GlmY ensures that it is continuously being turned over. This regulation
of glmS expression by GlmY and GlmZ provides a new example of a regulatory cas-
cade composed entirely of small noncoding RNAs. Considering the vast numbers of
small noncoding RNAs that have been and no doubt will continue to be identified,
RNA-based regulatory pathways may be more than just isolated oddities in a cell’s
regulatory arsenal.
J.H. Urban and J. Vogel (2008). PLoS 6, 631–642.
How Do miRNAs Do It?
MicroRNAs (miRNAs), identified in many organisms, may regulate gene expression through repression of mRNA translation.
The mechanism by which the binding of these imperfectly complementary small noncoding RNAs to target mRNAs accom-
plishes translational repression has been a critical question in the study of miRNAs. Using a new cell-free in vitro system that
reconstitutes miRNA translational repression, Wang et al. (2008) uncover evidence for how miRNA-mediated repression could
happen. It has been suggested that translational inhibition by miRNAs may occur at the step of translation initiation. However,
translation inhibition of the target mRNA does not seem to happen at the usual regulation steps, that is, either during formation
of the 43S preinitiation complex or during recruitment of this complex to the target mRNA. Instead, Wang et al. found that
translation repression may occur through a block in the joining of the 60S ribosomal subunit to the 40S subunit associated
with target mRNA, a specialized regulatory mechanism thought to be relevant for only certain mRNA transcripts. In their trans-
lational repression assay, the authors observed a significant decrease in the association of 60S ribosomal subunit compo-
nents with miRNA-targeted mRNAs, suggesting that translation is blocked by inhibiting the loading of the 60S subunit onto
the transcript. This loss of 60S subunit association was specific to reactions that successfully inhibited translation and was
not due to aberrant degradation of ribosomal subunits. Assays examining the binding of ribosomal and translational factors to
target mRNA further confirmed that translation inhibition occurs after completion of events immediately preceding the binding
of the 60S subunit, that is, successful binding of the 40S ribosomal subunit and of associated transcription initiation factors
eIF2 and eIF3 to the start codon. Future work will determine whether this intriguing model holds true in vivo and how it fits with
the functions of other known players in miRNA-mediated regulation of gene expression, such as the Argonaute proteins.
B. Wang et al. (2008). Proc. Natl. Acad. Sci. USA 105, 5343–5348.
Fat Cells Gain in Translation
One transcriptional target of the tumor suppressor protein p53 is Hzf, which encodes a zinc-finger protein that is involved in
hematopoiesis and the DNA damage response. Kawagishi et al. (2008) now report a third function for this zinc-finger protein:
regulating the differentiation of fat cells (adipocytes). Hzf expression is switched on in cultured mouse preadipocyte cells as
they differentiate into mature fat cells, and Hzf is highly expressed in the adipose tissue of mice in vivo. The authors deter-
mined that the Hzf protein directly regulates CCAAT/enhancer binding protein (C/EBPa), a transcription factor that is central
to adipocyte differentiation, by promoting translation of its transcript. They show that Hzf promotes translation using its three
nucleic acid binding zinc-finger motifs to interact directly with a specific RNA sequence in the 30 UTR of the C/EBPa transcript.
The authors speculate that Hzf may associate with other proteins on the C/EBPa transcript, perhaps to facilitate ribosomal
access. Cells depleted of Hzf had significantly lower amounts of C/EBPa protein and were unable to differentiate into adi-
pocytes. Indeed, in these cells, the C/EBPa mRNA showed dramatically decreased association with translating ribosomes.
Although adult mice lacking Hzf do not seem to have a defect in adipose tissue development, they do show glucose intoler-
ance and reduced insulin sensitivity, providing an intriguing link between regulation of adipogenesis and glucose metabolism.
T. Kawagishi et al. (2008). EMBO Journal. Published online April 17, 2008. 10.1038/emboj.2008.76.
Marie Z. Bao
Escherichia coli requires the small non-
coding RNAs GlmY or GlmZ for the ex-
pression of GlmS (indicated here by
GFP fluorescence), an essential enzyme
in amino-sugar metabolism. Image cour-
tesy of J. Vogel.Cell 133, May 16, 2008 ª2008 Elsevier Inc. 557
